Serum Vitamin D Levels do not Affect Susceptibility to EBV Infection. A Mendelian Randomization Study.
This Mendelian randomization study found no evidence that genetically proxied serum vitamin D levels causally influence susceptibility to Epstein-Barr virus infection, despite confirming a protective effect of vitamin D against multiple sclerosis.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
For decades, scientists have watched a curious pattern unfold in the human body: people with low levels of vitamin D seem more likely to develop multiple sclerosis, a condition where the immune system mistakenly attacks the protective coating of nerve fibers. At the same time, another piece of the puzzle has emerged, showing that infection with the Epstein-Barr virus, a common germ that stays dormant in most people after they catch it, is also strongly linked to the disease. Because vitamin D is made when skin touches sunlight, and sunlight is weaker at higher latitudes where multiple sclerosis is more common, researchers long suspected a direct connection. They wondered if low vitamin D might simply be the reason the virus becomes dangerous, or if the two factors work together to trigger the illness. To untangle this, they needed a way to see if vitamin D levels actually cause changes in how the body handles the virus, rather than just happening to occur at the same time.
To answer this, a team of researchers turned to a method that uses human genetics as a natural experiment. Instead of asking people to take vitamin supplements and waiting to see what happens, they looked at the DNA people were born with. Certain genes act like a natural dial, setting a person's vitamin D levels from birth and keeping them relatively steady throughout life. By studying millions of people, the researchers identified specific genetic markers that predict who would have higher or lower vitamin D levels naturally. They then checked if these same genetic markers also predicted whether a person was infected with the Epstein-Barr virus or if the virus was actively replicating in their blood or saliva. This approach removes the confusion of lifestyle factors, such as diet or time spent outdoors, which often muddy the waters in standard health studies.
The study examined a wide range of data, including whether people had antibodies showing they had ever met the virus, and whether they had active traces of the virus's genetic material floating in their blood or saliva. The researchers also included multiple sclerosis as a test case, because previous studies had already confirmed that lower vitamin D levels do indeed increase the risk of developing the disease. When they ran the numbers, the results for multiple sclerosis held true, confirming that genetically lower vitamin D levels are a genuine cause of higher risk for the condition. However, when they looked at the Epstein-Barr virus, the story changed completely. The genetic markers that predicted higher vitamin D levels showed no effect on whether a person carried the virus, how strong their immune response was to it, or whether the virus was actively reproducing in their system.
The findings suggest that vitamin D and the Epstein-Barr virus influence the risk of multiple sclerosis through separate paths. While low vitamin D levels appear to weaken the body's defenses in a way that allows multiple sclerosis to develop, they do not seem to make the virus itself more likely to infect a person or to become active. It is as if two different keys are turning two different locks to open the same door, rather than one key being required to turn the other. The researchers noted that their study focused on adults, and it is possible that vitamin D levels during childhood, when many people first catch the virus, might play a different role. But based on the data available from large groups of adults, there is no evidence that boosting vitamin D levels would change how the body controls the Epstein-Barr virus. This distinction is important because it tells scientists that to understand the disease, they must look at how vitamin D and the virus act independently, rather than assuming one simply controls the other.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.